|
Bloomberg reporting: Merck KGaA of Germany is gambling an unproven therapy that spurs the immune system to attack cancer cells will increase its share of a $48 billion oncology market More: 
|
Wednesday, November 4, 2009
| site search by freefind | advanced |
Schmuckraker: 2009 archive
Schmuckraker: 2008 archive
Schmuckraker: 2007 archive
Schmuckraker: 2006 archive
Schmuckraker: 2005 Archive
HorrorReport: 2004 archive
HorrorReport: 2003 archive
HorrorReport: 2002 archive
HorrorReport: 2001 archive
21nickels: 2000 archive
Personal: 1999 archive (first site)
<< Home